Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Deals Shaping The Medtech Industry, February 2022

Executive Summary

Medtech Insight's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment, in vitro diagnostics or medical devices, and then categorized by acquisition, alliance or financing. This month’s column covers deals announced in February 2022. Data provided by Biomedtracker

You may also be interested in...



Concerns And Hopes For Health Care Delivery In 2024

Industry experts from Norstella, whose data and technologies support decision making from R&D through to market access, shared their worries going into 2024.

Health Equity Drives Small Molecule Strategy At Serna Bio

Serna Bio is using machine learning and RNA biology to create a platform for the discovery of small molecule modulators of RNA. The startup will seek fresh funding in 2024 and is on the hunt for creative biopharma partnerships.

The State Of TechBio Going Into 2024

The long-term success of TechBio is dependent upon the flow of investment and alliances with mature life sciences companies. This collaborative model has proven many times over to be an ideal framework to develop new treatments for patients.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel